Syndax Case Study: Thesis Strengthening

Anna asks about names; Jonathan reviews Syndax’s launches, extended treatment duration data, NCCN listing, and why he’s holding patiently.

Transcript

Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!